Coya Therapeutics, Inc. Common Stock
Symbol: COYA (NASDAQ)
7.22
▲ (11.51%) 0.745
Company Description:
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
Key Stats
- Today's Open: $6.75
- Today's High: $7.54
- Today's Low: $6.351
- Today's Volume: 838.24K
- Yesterday Close: $6.47
- Yesterday High: $6.6841
- Yesterday Low: $6.19
- Yesterday Volume: 76.49K
- Last Min Volume: 1.00K
- Last Min High: $7.215
- Last Min Low: $7.215
- Last Min VWAP: $7.215
Company Profile
- Name: Coya Therapeutics, Inc. Common Stock
- Website: https://www.coyatherapeutics.com
- Listed Date: 2022-12-29
- Location: HOUSTON, TX
- Market Status: Active
- CIK Number: 0001835022
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $108.21M
- Round Lot: 100
- Outstanding Shares: 16.73M
- Asset Type: CS
RECENT FILINGS FOR COYA
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-02 | 8-K | View |
| 2025-08-19 | EFFECT | View |
| 2025-08-19 | 424B7 | View |
| 2025-08-19 | 4 | View |
| 2025-08-18 | CORRESP | View |
| 2025-08-13 | UPLOAD | View |
| 2025-08-12 | S-3 | View |
| 2025-08-12 | 10-Q | View |
| 2025-08-12 | 8-K | View |
| 2025-07-29 | 8-K | View |
| 2025-07-01 | 8-K | View |
| 2025-06-26 | 8-K | View |
| 2025-05-16 | ARS | View |
| 2025-05-16 | DEFA14A | View |
| 2025-05-16 | DEF 14A | View |
| 2025-05-13 | 10-Q | View |
| 2025-05-13 | 8-K | View |
| 2025-04-28 | 10-K/A | View |
| 2025-03-18 | 10-K | View |
| 2025-03-18 | 8-K | View |
Latest News on COYA